Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Edwin Schweiger is active.

Publication


Featured researches published by Edwin Schweiger.


Bioorganic & Medicinal Chemistry Letters | 2015

Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβ.

Ellen K. Kick; Richard Martin; Yinong Xie; Brenton T. Flatt; Edwin Schweiger; Tie-Lin Wang; Brett B. Busch; Michael Charles Nyman; Xiao-Hui Gu; Grace Yan; Brandee L. Wagner; Max Nanao; Lam Nguyen; Thomas J. Stout; Artur Plonowski; Ira G. Schulman; Jacek Ostrowski; Todd G. Kirchgessner; Ruth R. Wexler; Raju Mohan

A series of biaryl pyrazole and imidazole Liver X Receptor (LXR) partial agonists has been synthesized displaying LXRβ selectivity. The LXRβ selective partial agonist 18 was identified with potent induction of ATP binding transporters ABCA1 and ABCG1 in human whole blood (EC50=1.2μM, 55% efficacy). In mice 18 displayed peripheral induction of ABCA1 at 3 and 10mpk doses with no significant elevation of plasma or hepatic triglycerides at these doses, showing an improved profile compared to a full pan-agonist.


Journal of Organic Chemistry | 2013

Diastereoselective one-pot Knoevenagel condensation/Corey-Chaykovsky cyclopropanation.

Jeremy Clemens; Juliana L. Asgian; Brett B. Busch; Timothy Coon; Justin Ernst; Leonard Kaljevic; Paul Krenitsky; Timothy D. Neubert; Edwin Schweiger; Andreas Termin; Dean Stamos

Efforts to substitute the cyclopropane ring in a series of aryl cyclopropylnitriles led to the discovery of an operationally simple one-pot method for Knoevenagel condensation and subsequent Corey-Chaykovsky cyclopropanation giving diastereomerically pure products as a racemic mixture of enantiomers. Method development and results for variably substituted aryl acetonitriles and aldehydes in the reaction are reported. A concise synthesis of (±)-bicifadine in two steps is provided to demonstrate the utility of the method.


Archive | 2006

Pyrazole based lxr modulators

Brett B. Busch; Brenton T. Flatt; Xiao-Hui Gu; Shao-Po Lu; Richard Martin; Raju Mohan; Michael Charles Nyman; Edwin Schweiger; William C. Stevens; Tie-Lin Wang; Yinong Xie


Archive | 2003

Isoquinolinone derivatives and their use as therapeutic agents

Alan T. Johnson; Satoru Kaneko; Raju Mohan; Kozo Oda; Edwin Schweiger


Archive | 2007

LXR AND FXR MODULATORS

Brant Clayton Boren; Brett B. Busch; Xiao Hui Gu; Vasu Jammalamadaka; Shao Po Lu; Richard Martin; Raju Mohan; Edwin Schweiger; William C. Stevens; Tie Lin Wang; Yinong Xie; Wei Xu


Archive | 2003

Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof

Satoru Kaneko; Tsuyoshi Watanabe; Kozo Oda; Raju Mohan; Edwin Schweiger; Richard Martin


Archive | 2006

Imidazole based lxr modulators

Brett B. Busch; Brenton T. Flatt; Xiao-Hui Gu; Shao Po Lu; Richard Martin; Raju Mohan; Michael Charles Nyman; Edwin Schweiger; William C. Stevens; Tie-Lin Wang; Yinong Xie


Archive | 2009

Azabicyclo [3.2.1]octyl derivatives as 11 beta-hsd1 modulators

Richard Martin; Brenton T. Flatt; Jackline Eve Dalgard; Venkataiah Bollu; Ping Huang; Raju Mohan; Edwin Schweiger; Tie Lin Wang


Archive | 2005

Modulators of nuclear receptors

Christopher D. Bayne; Alan T. Johnson; Shao-Po Lu; Raju Mohan; Michael Charles Nyman; Edwin Schweiger; William C. Stevens; Haixia Wang; Yinong Xie; Lynne Canne Bannen; Diva Sze-Ming Chan; Ping Huang; Vasu Jammalamadaka; Richard George Khoury; Morrison B. Mac; Jason Jevious Parks; Yong Wang; Wei Xu


Archive | 2012

11 β-HSD1 modulators

Richard Martin; Brenton T. Flatt; Jackline Eve Dalgard; Venkataiah Bollu; Ping Huang; Raju Mohan; Edwin Schweiger; Tie-Lin Wang

Collaboration


Dive into the Edwin Schweiger's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge